RELATED CONTENT
NEWS
- 2009 results preview: big pharma grapples to varying degrees of success with generic erosion
- Mylan sued in US court over generic Caduet ANDA
- Biosimilar EPO and novel antidiabetics lead raft of Japanese approvals
- Democrats say drug price increases could wipe out PhRMA's $80 billion reform pledge
COMMENT
Other Informa Comment
EVENTS
Today
Berlin, Germany
Today
Berlin, Germany
22 March 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009


